Democratizing hedge fund level analysis tools for everyone
| Name | Diagnos Laboratorium Utama Tbk. |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Providers |
| Code | F1 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| PT. Bundamedik | 41.2 | 41.1 |
| PT. Bunda Investama Indonesia | 38.8 | 38.8 |
| Public < 5% | 20.0 | 20.1 |
| Source | 2022 | 2021 |
|---|---|---|
| DGNS | F1 | Doctor Referrals |
| DGNS | F1 | Corporate Clients |
| DGNS | F1 | Walk in Customers |
| DGNS | F1 | Others |
| Region | 2022 | 2021 |
|---|---|---|
| DGNS | F1 | Indonesia |
| DGNS | F1 | Others |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 1.21 | # 5 / 22 |
| EV_EBITDA | 28.73 | # 16 / 22 |
| PER | -45.43 | --- / 22 |
| PBV | 0.97 | # 4 / 22 |
| DER | 0.57 | # 13 / 22 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | -2.7704 | --- / 22 |
| ROA % | -1.4000000000000001 | --- / 22 |
| ROE % | -2.21 | --- / 22 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2021 | 9.6 | 1.2 |
| Timeframe | Performance |
|---|---|
| 1W % | 4.9 |
| 1Mo % | 6.4 |
| 3Mo % | -5.7 |
| 1Yr % | -45.6 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| SRAJ | -1,231.62 | 143.50 T | 147.48 T | 3,202 B | 469 B | -114 B |
| MIKA | 28.90 | 36.99 T | 36.33 T | 5,127 B | 1,945 B | 1,279 B |
| SILO | 27.25 | 24.91 T | 28.54 T | 12,210 B | 2,554 B | 914 B |
| HEAL | 51.37 | 23.05 T | 26.55 T | 6,777 B | 1,799 B | 450 B |
| PRAY | 64.86 | 11.03 T | 12.46 T | 2,201 B | 464 B | 170 B |
| CARE | 3,850.00 | 10.24 T | 10.66 T | 316 B | 79 B | 3 B |